Literature DB >> 11033234

Effects of arsenite on central monoamines and plasmatic levels of adrenocorticotropic hormone (ACTH) in mice.

J M Delgado1, L Dufour, J I Grimaldo, L Carrizales, V M Rodríguez, M E Jiménez-Capdeville.   

Abstract

We studied the effects of chronic arsenic exposure on brain monoamines and plasma levels of adrenocorticotropic hormone (ACTH) of mice. After weaning, mice received arsenic (0, 20, 40, 60 or 100 ppm) in drinking water over a period of 9 weeks. Monoamine content was quantified in different brain regions, arsenic was quantified in brain tissue and ACTH levels in plasma. Brain arsenic concentrations up to 200 ng/g showed a significant correlation with exposure levels and produced slight modifications in regional monoamine levels. ACTH plasma levels were significantly associated with norepinephrine (NE) concentrations in the medulla and pons, but not with hypothalamic NE levels. ACTH levels were significantly higher in the group exposed to 20 ppm. Dopamine showed significant dose-related decreases in the hypothalamus. These results show that chronic sodium arsenite exposure produces changes in central monoamines, which are not associated on a dose-dependent basis with major alterations in plasma ACTH.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11033234     DOI: 10.1016/s0378-4274(00)00240-x

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  6 in total

1.  Effects of prenatal exposure to sodium arsenite on motor and food-motivated behaviors from birth to adulthood in C57BL6/J mice.

Authors:  Vincent P Markowski; Elizabeth A Reeve; Kristen Onos; Mina Assadollahzadeh; Naomi McKay
Journal:  Neurotoxicol Teratol       Date:  2012-01-15       Impact factor: 3.763

2.  Perinatal exposure to 50 ppb sodium arsenate induces hypothalamic-pituitary-adrenal axis dysregulation in male C57BL/6 mice.

Authors:  Samantha L Goggin; Matthew T Labrecque; Andrea M Allan
Journal:  Neurotoxicology       Date:  2012-08-31       Impact factor: 4.294

3.  Moderate perinatal arsenic exposure alters neuroendocrine markers associated with depression and increases depressive-like behaviors in adult mouse offspring.

Authors:  Ebany J Martinez; Bethany L Kolb; Angela Bell; Daniel D Savage; Andrea M Allan
Journal:  Neurotoxicology       Date:  2008-05-21       Impact factor: 4.294

4.  Protective Effect of Curcumin by Modulating BDNF/DARPP32/CREB in Arsenic-Induced Alterations in Dopaminergic Signaling in Rat Corpus Striatum.

Authors:  Pranay Srivastava; Yogesh K Dhuriya; Richa Gupta; Rajendra K Shukla; Rajesh S Yadav; Hari N Dwivedi; Aditya B Pant; Vinay K Khanna
Journal:  Mol Neurobiol       Date:  2016-12-13       Impact factor: 5.590

5.  Lipid Metabolism Alterations in a Rat Model of Chronic and Intergenerational Exposure to Arsenic.

Authors:  Cesar Rivas-Santiago; Irma González-Curiel; Sergio Zarazua; Michael Murgu; Alonso Ruiz Cardona; Blanca Lazalde; Edgar E Lara-Ramírez; Edgar Vázquez; Julio Enrique Castañeda-Delgado; Bruno Rivas-Santiago; Jesús Adrián Lopez; Alberto R Cervantes-Villagrana; Yamilé López-Hernández
Journal:  Biomed Res Int       Date:  2019-10-15       Impact factor: 3.411

6.  Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels.

Authors:  Claire de Burbure; Jean-Pierre Buchet; Ariane Leroyer; Catherine Nisse; Jean-Marie Haguenoer; Antonio Mutti; Zdenek Smerhovsky; Miroslav Cikrt; Malgorzata Trzcinka-Ochocka; Grazyna Razniewska; Marek Jakubowski; Alfred Bernard
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.